Business Context and Reporting Period
Company: Lightwave Logic, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2012
Status: Development Stage Company
Business Overview: Lightwave Logic is a research and development company focused on developing Application Specific Electro-Optic Polymers (ASEOP) and Non-Linear All-Optical Polymers (NLAOP). The company aims to commercialize these materials for use in telecommunications, optical computing, satellite reconnaissance, and medical applications. As of the reporting date, the company had no commercial product revenue and relied on equity financing to fund operations.
Key Financial Metrics
| Metric | Three Months Ended Sept 30, 2012 | Nine Months Ended Sept 30, 2012 | Balance Sheet (Sept 30, 2012) |
|---|---|---|---|
| Net Sales | $3,200 | $0 | N/A |
| Net Loss | $(969,672) | $(2,868,623) | N/A |
| Operating Expenses | $969,797 | $2,748,510 | N/A |
| Cash and Cash Equivalents | N/A | N/A | $2,931,753 |
| Total Assets | N/A | N/A | $3,812,788 |
| Total Liabilities | N/A | N/A | $249,350 |
| Stockholders' Equity | N/A | N/A | $3,563,438 |
| Accumulated Deficit | N/A | N/A | $(26,728,124) |
Cash Flow (Nine Months Ended Sept 30, 2012):
- Net cash used in operating activities: $(1,775,800)
- Net cash used in investing activities: $(296,671)
- Net cash provided by financing activities: $4,644,400
Material Changes vs. Prior Period
- Revenue: The company recorded nominal net sales of $3,200 for the three months ended September 30, 2012, compared to $0 in the same period in 2011. No revenue was recorded for the nine-month period in either year.
- Operating Expenses: Operating expenses increased by $243,678 (33.6%) for the three months and $208,705 (8.2%) for the nine months compared to the prior year periods. This increase was driven by higher salaries, legal fees, laboratory rent, and depreciation due to the expansion of R&D activities and a new lab facility.
- Net Loss: Net loss increased to $(969,672) for the quarter and $(2,868,623) for the nine months, compared to $(726,187) and $(2,706,085) respectively in the prior year.
- Liquidity: Cash and cash equivalents increased significantly from $359,824 at December 31, 2011, to $2,931,753 at September 30, 2012, primarily due to financing activities.
Guidance, Outlook, and Risks
Outlook and Capital Resources:
Management believes the company has raised sufficient capital to finance operations through October 2013. The company expects to incur approximately $2.8 million in expenditures over the next 12 months. Future revenue is anticipated from prototype devices, application engineering charges, and material sales prior to full production.
Financing Agreement:
In May 2011, the company entered into an agreement with an institutional investor (Lincoln Park Capital Fund, LLC) to sell up to $20 million of common stock over 30 months. As of September 30, 2012, the investor had purchased shares totaling $4.4 million, with $15.3 million remaining available under the agreement.
Risks and Contingencies:
- Going Concern: The company has incurred substantial losses since inception and relies on equity financing. If the company cannot raise additional capital or generate revenue, there is substantial doubt about its ability to continue as a going concern beyond the current funding runway.
- Development Risks: Success depends on the ability to develop and commercialize proprietary polymer materials, which involves technical risks and delays in prototype development.
- Stock-Based Compensation: A significant portion of operating expenses consists of non-cash stock-based compensation, which dilutes existing shareholders.
Key Facts for Investor Verification
- Revenue Generation: Verify the timeline and feasibility of transitioning from a development stage to generating commercial revenue from prototype devices and material sales.
- Cash Burn Rate: Confirm the accuracy of the projected $2.8 million expenditure for the next 12 months against the current cash balance of ~$2.9 million.
- Institutional Investor Agreement: Review the terms of the $20 million stock purchase agreement with Lincoln Park Capital Fund, LLC, specifically the conditions required to obligate the investor to purchase shares.
- Stock Dilution: Assess the impact of ongoing stock issuances for services, commitment fees, and financing on existing shareholder equity.
- Patent Portfolio: Verify the status and commercial value of the granted patents (e.g., U.S. Patent No. 8,269,004) and pending applications.